Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine-Reference-Cited by-同舟云学术

Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine

Published:2008-08 Issue:8pt1 Volume:23 Page:1292-1297
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Sawaki Akira,Kanemitsu Yukihide,Mizuno Nobumasa,Takahashi Kuniyuki,Nakamura Tsuneya,Ioka Tatsuya,Tanaka Sachiko,Nakaizumi Akihiko,Salem Ahmed AS,Ueda Ryuzo,Yamao Kenji

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2006.04734.x/fullpdf

Reference28 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1997

2. An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma;Storniolo;Cancer,1999

3. Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine;Ziske;Br. J. Cancer,2003

4. Nonparametric estimation from incomplete observations;Kaplan;J. Am. Stat. Assoc.,1958

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study;Scientific Reports;2022-08-11

2. Perioperative Nursing of Patients with Pancreatic Cancer Treated with a Nanoknife;Journal of Nanoscience and Nanotechnology;2020-10-01

3. Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies;Journal of Gastrointestinal Oncology;2019-04

4. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors;International Journal of Cancer;2016-04-18

5. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review;PLOS ONE;2015-12-30